Efforts towards this have identified regulation of CD155, a checkpoint ligand for TIGIT, by FAK, and FAK expression is positively associated with TIGIT checkpoint ligands in human high grade serous ovarian cancer [39]. This evidence concerns the gene PTK2 and ovarian serous adenocarcinoma.